Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

499 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Derivation and validation of a novel functional FFRCT score incorporating the burden of coronary stenosis severity and flow impairment to predict clinical events.
Gabara L, Hinton J, Kira M, Saunders A, Shambrook J, Abbas A, Leipsic JA, Rogers C, Mullen S, Ng N, Wilding S, Douglas PS, Patel M, Fairbairn TA, Hlatky MA, Curzen N. Gabara L, et al. Among authors: hlatky ma. J Cardiovasc Comput Tomogr. 2024 Jan-Feb;18(1):33-42. doi: 10.1016/j.jcct.2023.10.005. Epub 2023 Oct 21. J Cardiovasc Comput Tomogr. 2024. PMID: 37872028 Free article.
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Neal B, Perkovic V, Mahaffey KW, de Zeeuw D, Fulcher G, Erondu N, Shaw W, Law G, Desai M, Matthews DR; CANVAS Program Collaborative Group. Neal B, et al. N Engl J Med. 2017 Aug 17;377(7):644-657. doi: 10.1056/NEJMoa1611925. Epub 2017 Jun 12. N Engl J Med. 2017. PMID: 28605608 Free article. Clinical Trial.
Cost analysis of CYP2C19 genetic testing in percutaneous coronary intervention patients.
Huxley S, Moriarty J, Hlatky MA, Lennon R, Bailey K, Bell M, Geller N, Lerman A, Mathew V, Rosenberg Y, Farkouh M, Rihal C, Borah B, Pereira NL. Huxley S, et al. Among authors: hlatky ma. Pharmacogenomics J. 2024 Oct 8;24(6):32. doi: 10.1038/s41397-024-00353-y. Pharmacogenomics J. 2024. PMID: 39379363 Clinical Trial.
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Goodman SG, Steg PG, Szarek M, Bhatt DL, Bittner VA, Diaz R, Harrington RA, Jukema JW, White HD, Zeiher AM, Manvelian G, Pordy R, Poulouin Y, Stipek W, Garon G, Schwartz GG; ODYSSEY OUTCOMES Investigators. Goodman SG, et al. Eur Heart J Cardiovasc Pharmacother. 2024 Jul 16;10(4):342-352. doi: 10.1093/ehjcvp/pvae025. Eur Heart J Cardiovasc Pharmacother. 2024. PMID: 38658193 Free PMC article. Review.
Prevalence of frequent premature ventricular contractions and nonsustained ventricular tachycardia in older women screened for atrial fibrillation in the Women's Health Initiative.
Gomez SE, Larson J, Hlatky MA, Rodriguez F, Wheeler M, Greenland P, LaMonte M, Froelicher V, Stefanick ML, Wallace R, Kooperberg C, Tinker LF, Schoenberg J, Soliman EZ, Vitolins MZ, Saquib N, Nuño T, Haring B, Perez MV. Gomez SE, et al. Among authors: hlatky ma. Heart Rhythm. 2024 Aug;21(8):1280-1288. doi: 10.1016/j.hrthm.2024.02.040. Epub 2024 Feb 23. Heart Rhythm. 2024. PMID: 38403238 Clinical Trial.
Fractional Flow Reserve-Guided PCI or Coronary Bypass Surgery for 3-Vessel Coronary Artery Disease: 3-Year Follow-Up of the FAME 3 Trial.
Zimmermann FM, Ding VY, Pijls NHJ, Piroth Z, van Straten AHM, Szekely L, Davidavicius G, Kalinauskas G, Mansour S, Kharbanda R, Östlund-Papadogeorgos N, Aminian A, Oldroyd KG, Al-Attar N, Jagic N, Dambrink JE, Kala P, Angeras O, MacCarthy P, Wendler O, Casselman F, Witt N, Mavromatis K, Miner SES, Sarma J, Engstrøm T, Christiansen EH, Tonino PAL, Reardon MJ, Otsuki H, Kobayashi Y, Hlatky MA, Mahaffey KW, Desai M, Woo YJ, Yeung AC, De Bruyne B, Fearon WF; FAME 3 Investigators. Zimmermann FM, et al. Among authors: hlatky ma. Circulation. 2023 Sep 19;148(12):950-958. doi: 10.1161/CIRCULATIONAHA.123.065770. Epub 2023 Aug 21. Circulation. 2023. PMID: 37602376 Free article. Clinical Trial.
499 results